Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-001612)

Filing Details

Accession Number:: 0001209191-19-001612
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-03 21:03:04
Reporting Period:: 2018-12-31

Accepted Time:: 2019-01-03 21:03:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1390478	Sellas Life Sciences Group Inc.	SLS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724253	M. Angelos Stergiou	C/O Sellas Life Sciences Group, Inc. 15 West 38Th Street, 10Th Floor New York NY 10018	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-12-31	23,277	$1.25	426,858	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The Reporting Person sold such shares to cover personal income tax liability.
The price reported is a weighted average price. The shares were sold at prices ranging from $1.23 to $1.31 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.